Valrubicin

In the US, Valrubicin (valrubicin systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Urinary Tract Tumors.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01DB09

CAS registry number (Chemical Abstracts Service)

0056124-62-0

Chemical Formula

C34-H36-F3-N-O13

Molecular Weight

723

Therapeutic Category

Antineoplastic agent: Cytotoxic antibacterial from the group of anthracyclines (semisynthetic analogue)

Chemical Name

(8S, 10S)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 8²-valerate (WHO)

Foreign Names

  • Valrubicinum (Latin)
  • Valrubicin (German)
  • Valrubicine (French)
  • Valrubicina (Spanish)

Generic Names

  • Valrubicin (OS: USAN)
  • AD 32 (IS)
  • NSC 246131 (IS)
  • Valrubicin (PH: USP 34)

Brand Names

  • Valstar
    Celltech, United States; Endo, United States

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web2)